- Home
- JAZZ vs BILL Comparison
JAZZ vs BILL Comparison
Compare JAZZ & BILL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAZZ
- BILL
- Stock Information
- Founded
- JAZZ 2003
- BILL 2006
- Country
- JAZZ Ireland
- BILL United States
- Employees
- JAZZ N/A
- BILL N/A
- Industry
- JAZZ Biotechnology: Pharmaceutical Preparations
- BILL EDP Services
- Sector
- JAZZ Health Care
- BILL Technology
- Exchange
- JAZZ Nasdaq
- BILL Nasdaq
- Market Cap
- JAZZ 7.3B
- BILL 6.0B
- IPO Year
- JAZZ 2007
- BILL 2019
- Fundamental
- Price
- JAZZ $121.18
- BILL $88.90
- Analyst Decision
- JAZZ Buy
- BILL Buy
- Analyst Count
- JAZZ 14
- BILL 21
- Target Price
- JAZZ $173.93
- BILL $87.20
- AVG Volume (30 Days)
- JAZZ 567.6K
- BILL 3.2M
- Earning Date
- JAZZ 02-26-2025
- BILL 02-06-2025
- Dividend Yield
- JAZZ N/A
- BILL N/A
- EPS Growth
- JAZZ 458.10
- BILL N/A
- EPS
- JAZZ 7.04
- BILL 0.07
- Revenue
- JAZZ $3,992,712,000.00
- BILL $1,343,637,000.00
- Revenue This Year
- JAZZ $7.51
- BILL $15.18
- Revenue Next Year
- JAZZ $6.84
- BILL $15.01
- P/E Ratio
- JAZZ $17.22
- BILL $1,165.40
- Revenue Growth
- JAZZ 5.23
- BILL 18.54
- 52 Week Low
- JAZZ $99.06
- BILL $43.11
- 52 Week High
- JAZZ $134.17
- BILL $97.86
- Technical
- Relative Strength Index (RSI)
- JAZZ 46.66
- BILL 56.55
- Support Level
- JAZZ $118.72
- BILL $79.43
- Resistance Level
- JAZZ $124.66
- BILL $90.50
- Average True Range (ATR)
- JAZZ 2.82
- BILL 3.03
- MACD
- JAZZ -0.21
- BILL 0.06
- Stochastic Oscillator
- JAZZ 31.62
- BILL 85.55
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
About BILL BILL Holdings Inc.
BILL Holdings Inc is a provider of software-as-a-service, cloud-based payments and spend and expense management products, which allow users to automate accounts payable and accounts receivable transactions, enable businesses to easily connect with their suppliers or customers to do business, eliminate expense reports, manage cash flows and improve back office efficiency. Initial Public Offering and Follow-on Offering.